Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro
Authors
Keywords
-
Journal
EBioMedicine
Volume 74, Issue -, Pages 103712
Publisher
Elsevier BV
Online
2021-11-25
DOI
10.1016/j.ebiom.2021.103712
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
- (2021) Summer E. Galloway et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- The great escape? SARS-CoV-2 variants evading neutralizing responses
- (2021) Jérémie Prévost et al. Cell Host & Microbe
- SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities
- (2021) Rochelle P. Walensky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses
- (2021) Eleazar Ramírez Hernández et al. VIRAL IMMUNOLOGY
- SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity
- (2021) Muthukumar Ramanathan et al. LANCET INFECTIOUS DISEASES
- Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
- (2021) Sreejith Rajasekharan et al. Viruses-Basel
- Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
- (2021) Cheng-Pu Sun et al. PLoS Pathogens
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic
- (2020) EUROPEAN JOURNAL OF HUMAN GENETICS
- Site-specific glycan analysis of the SARS-CoV-2 spike
- (2020) Yasunori Watanabe et al. SCIENCE
- Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
- (2020) Yasunori Watanabe et al. Nature Communications
- Recent advances of antibody drug conjugates for clinical applications
- (2020) Pengxuan Zhao et al. Acta Pharmaceutica Sinica B
- Coronavirus membrane fusion mechanism offers a potential target for antiviral development
- (2020) Tiffany Tang et al. ANTIVIRAL RESEARCH
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
- (2020) Peng Zhao et al. Cell Host & Microbe
- Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes
- (2020) Uri Galili VACCINE
- Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
- (2020) Oliver C. Grant et al. Scientific Reports
- Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
- (2020) Lorenzo Casalino et al. ACS Central Science
- N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects
- (2020) Cristiane J. Nunes-Santos et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
- (2020) Ralf Kircheis et al. Frontiers in Immunology
- Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunction
- (2019) Hua Lu et al. FASEB JOURNAL
- Exploitation of glycosylation in enveloped virus pathobiology
- (2019) Yasunori Watanabe et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
- (2019) Heng-Huan Lee et al. CANCER CELL
- Comprehensive Interactome Analysis Reveals that STT3B is Required for the N-Glycosylation of Lassa Virus Glycoprotein
- (2019) Shenglin Zhu et al. JOURNAL OF VIROLOGY
- Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
- (2018) Cecilia Lopez Sambrooks et al. CANCER RESEARCH
- Loss and gain of N-linked glycosylation sequons due to single-nucleotide variation in cancer
- (2018) Yu Fan et al. Scientific Reports
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells
- (2016) Cecilia Lopez-Sambrooks et al. Nature Chemical Biology
- Adaptive immune activation: glycosylation does matter
- (2013) Margreet A Wolfert et al. Nature Chemical Biology
- Novel detection of DNA-alkylated adducts of antibody–drug conjugates with potentially unique preclinical and biomarker applications
- (2013) Lourdes Thevanayagam et al. Bioanalysis
- N-Linked Protein Glycosylation in the Endoplasmic Reticulum
- (2013) J. Breitling et al. Cold Spring Harbor Perspectives in Biology
- Antibody-Drug Conjugates in Cancer Therapy
- (2012) Eric L. Sievers et al. Annual Review of Medicine
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Proteins Incorporated into Infectious Virions
- (2010) F. Helle et al. JOURNAL OF VIROLOGY
- N-Linked Glycosylation Facilitates Sialic Acid-Independent Attachment and Entry of Influenza A Viruses into Cells Expressing DC-SIGN or L-SIGN
- (2010) S. L. Londrigan et al. JOURNAL OF VIROLOGY
- Cotranslational and Posttranslational N-Glycosylation of Polypeptides by Distinct Mammalian OST Isoforms
- (2009) Catalina Ruiz-Canada et al. CELL
- Metabolism, Cell Surface Organization, and Disease
- (2009) James W. Dennis et al. CELL
- Proximal Glycans Outside of the Epitopes Regulate the Presentation of HIV-1 Envelope gp120 Helper Epitopes
- (2009) Hualin Li et al. JOURNAL OF IMMUNOLOGY
- The repertoire of glycan determinants in the human glycome
- (2009) Richard D. Cummings Molecular BioSystems
- Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
- (2008) Shunxin Wang et al. VIRUS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now